Market Tracker

07/06 4:04pm ET

Theravance Inc (NASDAQ:THRX)

16.02
Delayed Data
As of 3:59pm ET
 -0.85 / -5.04%
Today’s Change
10.58
Today|||52-Week Range
30.56
+13.22%
Year-to-Date

Today’s Trading

Previous close16.87
Today’s open16.75
Day’s range15.77 - 16.84
Volume574,831
Average volume (3 months)625,979
Market cap$2.0B
Dividend yield6.24%
Data as of 3:59pm ET, 07/06/2015

Growth & Valuation

Earnings growth (last year)+10.18%
Earnings growth (this year)+90.11%
Earnings growth (next 5 years)-464.61%
Revenue growth (last year)+309.82%
P/E ratioNM
Price/Sales81.32
Price/Book--

Competitors

 Today’s
change
Today’s
% change
SAGESAGE Therapeutics In...+0.39+0.57%
ADROAduro Biotech Inc-0.11-0.35%
LGNDLigand Pharmaceutica...+0.25+0.25%
GLPGGalapagos NV+1.03+2.03%
Data as of 3:59pm ET, 07/06/2015

Financials

Next reporting dateJuly 23, 2015
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$19.5M
Annual profit (last year)-$168.5M
Net profit margin-377.10%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Michael W. Aguiar
Chief Financial Officer &
Senior Vice President
Eric d'Esparbes
Corporate headquarters
South San Francisco, California

Forecasts